MerckMRK stock jumped Tuesday on a surprise win for its drug sotatercept in patients with pulmonary hypertension. But one analyst cautioned that the company still has a long road in front of it. The ...
Monday - Friday, 6:00 - 7:00 PM ET Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, Keytruda, and he described other ventures in ...
Zacks Investment Research on MSN
Merck's anti-TL1A antibody meets goal in ulcerative colitis study
Merck MRK announced positive results from Study 2 of the late-stage ATLAS-UC study, which evaluated tulisokibart, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results